Challenges for the standardized reporting of NGS HLA genotyping: Surveying gaps between clinical and research laboratories

Hum Immunol. 2021 Nov;82(11):820-828. doi: 10.1016/j.humimm.2021.08.011. Epub 2021 Sep 1.

Abstract

Next generation sequencing (NGS) is being applied for HLA typing in research and clinical settings. NGS HLA typing has made it feasible to sequence exons, introns and untranslated regions simultaneously, with significantly reduced labor and reagent cost per sample, rapid turnaround time, and improved HLA genotype accuracy. NGS technologies bring challenges for cost-effective computation, data processing and exchange of NGS-based HLA data. To address these challenges, guidelines and specifications such as Genotype List (GL) String, Minimum Information for Reporting Immunogenomic NGS Genotyping (MIRING), and Histoimmunogenetics Markup Language (HML) were proposed to streamline and standardize reporting of HLA genotypes. As part of the 17th International HLA and Immunogenetics Workshop (IHIW), we implemented standards and systems for HLA genotype reporting that included GL String, MIRING and HML, and found that misunderstanding or misinterpretations of these standards led to inconsistencies in the reporting of NGS HLA genotyping results. This may be due in part to a historical lack of centralized data reporting standards in the histocompatibility and immunogenetics community. We have worked with software and database developers, clinicians and scientists to address these issues in a collaborative fashion as part of the Data Standard Hackathons (DaSH) for NGS. Here we report several categories of challenges to the consistent exchange of NGS HLA genotyping data we have observed. We hope to address these challenges in future DaSH for NGS efforts.

Keywords: Allelic ambiguity; GL String; Genotypic ambiguity; HML; MIRING.

MeSH terms

  • Genotyping Techniques / methods*
  • Genotyping Techniques / standards
  • HLA Antigens / genetics
  • High-Throughput Nucleotide Sequencing / standards*
  • Histocompatibility Testing / methods*
  • Histocompatibility Testing / standards
  • Humans
  • Immunogenetics / methods
  • Immunogenetics / standards*
  • Laboratories / standards*
  • Sequence Analysis, DNA / methods
  • Sequence Analysis, DNA / standards
  • Software

Substances

  • HLA Antigens